Tuesday, June 11, 2019 2:47:23 PM
https://www.thegrowthop.com/cannabis-business/cannabis-small-business/nosing-out-the-cannabis-competition-u-s-patent-sniffs-intellectual-property-rights-for-terpene-based-pesticide
Digipath files provisional patent for terpene technology to help put a stopper on costly mould infections in cannabis and hemp cultivation
“Mould presents a difficult problem for many cannabis cultivators, resulting in a failure rate of approximately 10 percent flower harvests in Nevada, with higher failure rates in California,” the company reports. “Mould infections cost cultivators significant money and time, and present potential health risks for consumers,” it adds.
With regard to pesticides, “through its testing lab operations in Nevada, Digipath has observed a roughly one percent failure rate of cannabis flower submitted for testing due to pesticide issues. Results in neighbouring states like California are significantly worse, upwards of 20 percent in some areas,” the company press release states.
Though the company’s efforts are focused on its core market of cannabis, Digipath’s “science team believes that there are other large agricultural markets for this technology.”
Recent DIGP News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 04:57:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 03:41:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 10:27:03 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/16/2024 10:17:16 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/02/2024 07:28:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 06:18:09 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 07:33:42 PM
- Digipath, Inc. Signs Agreement to Sell the Assets of Its Lab Subsidiary • InvestorsHub NewsWire • 05/05/2023 12:46:35 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM